The QualityStocks Daily Stock List
- Bearing Lithium Corp. (BLILF)
- Blueberries Medical Corp. (BBRRF)
- BorrowMoney.com, Inc. (BWMY)
- Enterprise Diversified, Inc. (SYTE)
- Grom Social Enterprises, Inc. (GRMM)
- Halo Labs Inc. (AGEEF)
- Peeks Social Ltd. (PKSLF)
- BlackStar Enterprise Group, Inc. (BEGI)
- Veritas Farms, Inc. (VFRM)
- Integrity Applications, Inc. (IGAP)
- Alpine 4 Technologies Ltd. (ALPP)
- Bravada Gold Corp. (BGAVF)
- Guided Therapeutics, Inc. (GTHP)
- HD View 360, Inc. (HDVW)
Bearing Lithium Corp. (BLILF)
StockAP, OTC Markets, Vanadium Report, Junior Mining Network, The Prospector News, InvestorX, Investor Ideas, Metals Channel, TMXmoney, Morningstar, Investing.com, TeleTrader, Wallet Investor, Dividend Investor, Ceo.ca, Stockhouse, Dividend.com, and InvestorsHub reported beforehand on Bearing Lithium Corp. (BLILF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Bearing Lithium Corp. is a lithium-focused mineral exploration and development company. The Company’s chief asset is an 18 percent interest in the Maricunga Lithium Brine Project in Chile. The Maricunga Project represents one of the highest-grade lithium brine salars internationally and the only pre-production project in Chile. Bearing Lithium has its corporate headquarters in Vancouver, British Columbia.
Greater than US$30 million has been invested in the Maricunga Project so far. In addition, all expenditures through to the delivery of a Definitive Feasibility Study (DFS) have been fully-funded by the earn-in joint-venture (JV) partner. The Maricunga Project represents one of the few projects at the development stage in Latin America. The Maricunga Project is one of only two brine projects held by publicly-traded companies at a DFS-stage in the world.
The Maricunga Lithium Brine Project is host to an NI 43-101 M&I resource of 2.1 million tonnes of lithium carbonate equivalent (LCE) at a grade of 1,170 mg/L lithium (Li). A 2019 DFS outlined production of 20,000 tpa LCE at a cash cost of US$3,772/t LCE over a 23-year mine life that generated an after-tax NPV (Net Present Value) 8 percent of US$908 million, IRR (Internal Rate of Return) of 21.0 percent, and 4.2-year payback including a 2-year ramp-up.
Last month, Bearing Lithium announced that the Chilean Environmental Service notified Minera Salar Blanco S.A. (MSB), the operating company for the Maricunga JV, it extended the Environmental Impact Assessment (EIA) evaluation process for 60 days. Bearing Lithium holds an 18 percent interest in MSB, along with Lithium Power International (LPI-ASX) at 51 percent and a private Chilean company at 31 percent.
Cristobal Garcia-Huidobro, MSB's Chief Executive Officer, said, "We expect an approval for our EIA to be granted in Q1/20 at the completion of the Environmental Service's review process. This extension does not have any impact on the financial structuring process currently underway, nor does it impact the finalization of the joint venture with CODELCO, which is simultaneously being worked on."
Bearing Lithium Corp. (BLILF), closed Tuesday's trading session at $0.1119, off by 3.2844%, on 25,065 volume with 10 trades. The average volume for the last 3 months is 4,838 and the stock's 52-week low/high is $0.105999998/$0.285199999.
Blueberries Medical Corp. (BBRRF)
Midas Letter, InvestorX, Morningstar, Market Screener, Stockwatch, Small Cap Power, Street Insider, PR Newswire, Profit Confidential, GlobeNewswire, Technical420, Wallet Investor, Nasdaq, NIC Investors, Dividend Investor, Stockhouse, Financial Buzz, InvestorsHub, Investing.com, and TradingView reported previously on Blueberries Medical Corp. (BBRRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Blueberries Medical Corp. is a Latin American licensed producer of medicinal cannabis and cannabis-derived products. It is a producer of naturally grown premium quality cannabis with its principal operations ideally located in the Bogotá Savannah of central Colombia and operations currently being established in Argentina. In Argentina, the OTCQB-listed Company is advancing a pilot project in a joint venture (JV) with the State-owned company Cannava. Blueberries Medical is headquartered in Bogotá, Colombia.
A specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing leads Blueberries Medical. The Company is fully licensed for the cultivation, production, domestic distribution, and global export of CBD (cannabidiol) and THC-based (tetrahydrocannabinol) medical cannabis in Colombia. Blueberries Medical’s combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned it to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.
Concerning cannabis oil extracts, Blueberries Medical develops high-end medicinal products for the treatment of many human conditions. The Company works together with small producers in the region of the Bogota Savanna and supplies medicinal cannabis products to the national and worldwide market.
Blueberries Medical has a large cultivation footprint with scalable growing capacity through contract growers. It has 142 exclusive Colombian cannabis strains with high CBD and THC contents. In addition, it has strong international partnerships for product development and distribution.
This past September, Blueberries Medical announced that it received approval from the Colombian Institute of Agriculture (ICA) for the registration of five proprietary non-psychoactive CBD strains with the national cultivar registry and to begin commercial production of these strains. The registration and approval to begin commercial production is among the first to be issued in Colombia and a significant milestone for the Company.
Blueberries Medical has now completed all regulatory requirements to start commercial cultivation and sales in Colombia and export to global markets. It immediately started cultivation of standardized medicinal-grade cannabis for oil extract.
Recently, Blueberries Medical announced that it has partnered with the Van Uden International Center for Alternative Medicine and the Juan N. Corpas University Foundation, two distinguished Colombian organizations in the health and academic fields. The partnerships will facilitate the distribution of Blueberries Medical’s products to a patient network of greater than 12,000 and bridge the gap between research and clinical practice by educating physicians on the applications and benefits of medicinal cannabis treatments.
Patricio Stocker, Chief Executive Officer of Blueberries Medical, said, “We are proud to team up with two prominent organizations and share our extensive knowledge and expertise on medicinal cannabis. Their teams will provide valuable guidance and strategic opportunities for us to extend our reach within Colombia and beyond.”
Blueberries Medical Corp. (BBRRF), closed Tuesday's trading session at $0.07585, up 1.1333%, on 41,040 volume with 44 trades. The average volume for the last 3 months is 49,874 and the stock's 52-week low/high is $0.029999999/$0.649999976.
BorrowMoney.com, Inc. (BWMY)
NetworkNewsWire, Stock Target Advisor, Penny Stock Base, TeleTrader, Last10k, Market Screener, Nasdaq, Investors Hangout, Stockopedia, Wallstreet:online, InvestorsHub and MarketWatch reported earlier on BorrowMoney.com, Inc. (BWMY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BorrowMoney.com, Inc. operates an online loan marketplace site. This product can be used by customers to connect with numerous lenders for financial borrowing needs, to track their credit score, and review all loans, and credit card accounts. The Company is not a lender. At present, it can intake consumer applications and inquiries for submission to participating lenders who receive consumer credit requests that are received online from consumers. Established in 2000 and listed on the OTC Markets, BorrowMoney.com has its head office in Fort Lauderdale, Florida.
The Company’s internet platform provides a portal geared toward providing services to lending institutions who would be its customers. The main function of its platform is to provide qualified leads to local mortgage and lending professionals. Fundamentally, BorrowMoney.com is a FinTech lending exchange empowering consumers, lenders, as well as related service providers.
BorrowMoney.com’s primary goal is to provide a service for the internet mortgage and loan provider business. The Company’s business model envisions providing current, qualified leads to local lending institutions who are presently members of the National Mortgage Listing Service. These leads will represent qualified borrowers in targeted zip code locations where the lender does business.
Regarding its process, the first step is a Credit Request. Consumers access the Company’s exchange at www.BorrowMoney.com or sites and select a loan product from its numerous loan categories. Consumers complete a single qualification form for the selected loan product with information such as income, assets and liabilities, loan preferences and other data.
In addition, Consumers consent to BorrowMoney.com’s retrieval of their credit report. The next step is Qualification Form Filtering and Transmission. The Company’s filtering process matches the consumer's qualification form data, credit profile, and geographic location to the pre-set underwriting criteria provided by participating Lenders. Lenders are able to modify their underwriting criteria in real-time directly via a password-protected Website upon BorrowMoney.com’s proprietary platform. Once qualification forms pass the filters, they are transmitted to up to three Lenders who have subscribed to the Company’s marketplace whose lending criteria match that of the consumers' profile and location.
BorrowMoney.com, Inc. (BWMY), closed Tuesday's trading session at $2.00, even for the day, on 1,900 volume with 3 trades. The average volume for the last 3 months is 126 and the stock's 52-week low/high is $2.00/$2.00.
Enterprise Diversified, Inc. (SYTE)
Insider Monkey, Market Screener, TipRanks, Morningstar, OTC Dynamics, Stockhouse, AI Stock Finder, PR Newswire, 4-Traders, TradingView, Stockopedia, Tech Know Bits, Whale Wisdom, Investing.com, and MarketBeat reported beforehand on Enterprise Diversified, Inc. (SYTE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Enterprise Diversified, Inc. is chiefly an alternative asset manager with interests in several diverse business activities in the asset management, real estate, and internet access industries. Its companies include Willow Oak Asset Management and Sitestar.net. The Company was previously known as Sitestar Corporation. It changed its name to Enterprise Diversified, Inc. in July of 2018. OTCQB-listed, Enterprise Diversified is based in Richmond, Virginia.
Willow Oak Asset Management holds interests in private investment partnerships. Through its Fund Management Services, Willow Oak provides operational, marketing, and investor relations support to niche fund managers.
Enterprise Diversified's Internet Operations are managed under Sitestar.net. Sitestar.net offers consumer and business-grade internet access, wholesale managed modem services, web hosting, and varied ancillary services to customers in the U.S. (with a high concentration in the northeastern region) and Canada. Sitestar.net is a high-quality internet service provider. It provides products such as Fiber, DSL, Dial-up and Accelerated Dial-up, Email, and Web Hosting services, among others.
Furthermore, Enterprise Diversified directly owns a real estate investment portfolio. This portfolio includes residential properties, vacant land, and one commercial property. This portfolio is mainly focused in the Roanoke and Lynchburg areas of Virginia.
Enterprise Diversified also holds a 35 percent ownership stake in a Lexington, Kentucky-based real estate holding company. It holds this via a partnership with a third-party operator. This portfolio consists of residential and commercial properties.
This past September, Willow Oak Asset Management and Focused Compounding announced the launch of a new private investment partnership to commence investing on January 1, 2020. This fund will be managed by Mr. Geoff Gannon of Focused Compounding with assistance from his colleague, Mr. Andrew Kuhn.
Willow Oak's Fund Management Services will financially and logistically facilitate the launch of the fund. It will also provide operational support via an ongoing, permanent relationship. Willow Oak will own a stake in Focused Compounding's management company and earn a revenue fee share at the management-company level.
This month, Enterprise Diversified announced its financial results for Q3 ending September 30, 2019, in connection with filing its quarterly report on Form 10-Q with the Securities and Exchange Commission (SEC). Its wholly owned asset management subsidiary, Willow Oak Asset Management, is the main emphasis of Enterprise Diversified, providing the greatest potential for value creation with little capital requirement.
Willow Oak's direct investment in Alluvial Fund, valued at $9,466,387 as of September 30, 2019, is the principal driver of the subsidiary's gains and losses in any given quarter. Additional revenue attributable to the subsidiary is produced by fee share arrangements with managed funds on the Willow Oak platform and fees earned from Willow Oak's Fund Management Services. As of September 30, 2019, the funds on the platform include Alluvial Fund, Bonhoeffer Fund, and Arquitos Capital.
Enterprise Diversified, Inc. (SYTE), closed Tuesday's trading session at $4.01, up 0.25%, on 1,688 volume with 5 trades. The average volume for the last 3 months is 1,813 and the stock's 52-week low/high is $4.00/$10.6999998.
Grom Social Enterprises, Inc. (GRMM)
Stock Pulse, VentureLine, Chasing Markets, Proactive Investors, TipRanks, OTC Markets, Whale Wisdom, Stockwatch, Market Screener, Morningstar, PR Newswire, Wallet Investor, Stockhouse, Dividend Investor, Last10k, InvestorsHub, Stockopedia, TradingView, Simply Wall St, Dividend.com and Nasdaq reported earlier on Grom Social Enterprises, Inc. (GRMM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Grom Social Enterprises, Inc., by way of its subsidiaries, operates a social media network designed for children in the USA. Fundamentally, the Company is the developer of Grom Social, a top social media platform for kids. It is also an original children’s entertainment content provider. Grom provides these for children 13 years of age and under. It provides safe and secure digital environments for kids that can be monitored by their parents or guardians. OTCQB-listed, Grom Social Enterprises is based in Boca Raton, Florida.
Grom Social Enterprises has a number of operating subsidiaries. These include the above-mentioned Grom Social, which delivers its content via mobile and desktop environments (web portal and apps) that entertain children, let them interact with friends, access relevant news, and play proprietary games, while teaching them about being a good digital citizen. The Company’s emphasis here is making the internet safe for kids through teaching and monitoring, giving parents the tools they need for peace of mind.
In addition, Grom owns and operates Top Draw Animation, Inc. Top Draw Animation (a leading 2D animation firm) produces award-winning animation content for some of the largest worldwide media companies. Furthermore, Grom Social Enterprises includes Grom Educational Services, which has provided web filtering services for K-12 schools, government, as well as private business.
This past August, Grom Social Enterprises announced that its wholly owned subsidiary, Top Draw Animation (TDA), entered the lucrative 3D animation space in collaboration with an undisclosed tier-1 entertainment and media giant. In addition to its present production personnel of 500 2D animators, TDA is estimating an initial injection of 80 to 100 skilled 3D artists and technical personnel. In August it had already started the hiring process. The 3D division, in terms of people, is projected to double within the medium term.
TDA is now 20 years old. It produces such well known cartoon animation as Tom and Jerry, The Hollow, and My Little Pony, among others. TDA works with the likes of DreamWorks, Nickelodeon, and Disney Television Animation among a wider array of blue chip, global producers.
Grom Social Enterprises, Inc. (GRMM), closed Tuesday's trading session at $0.09, off by 7.5596%, on 73,105 volume with 16 trades. The average volume for the last 3 months is 31,909 and the stock's 52-week low/high is $0.090000003/$0.300000011.
Halo Labs, Inc. (AGEEF)
Hot Stocks Review, Value The Markets, Small Cap Power, Green Market Report, Midas Letter, New Cannabis Ventures, TMXmoney, Morningstar, OTC Markets, Stockwatch, Market Screener, TeleTrader, InvestorsHub, MarketWatch and Stockhouse reported earlier on Halo Labs, Inc. (AGEEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Halo Labs, Inc. is a cannabis extraction company listed on the OTC Markets Group’s OTCQX. It develops and manufactures quality cannabis oils and concentrates. At present, Halo Labs is operating in California and Oregon, and also in Nevada with its partner Just Quality, LLC, and in Lesotho with the Bophelo strategic partnership. In addition, it recently acquired Dispensary Track platform, which will ease customer flow constraints experienced by dispensaries and enable direct consumer interaction. Halo Labs is headquartered in Toronto, Ontario.
In essence, the Company is a leader in cannabis extraction employing proprietary science based techniques and developing unique products. Halo Labs is at the forefront of contemporary cannabis extraction techniques and cannabinoid isolation. It possesses proprietary trade secrets and pioneering technology that is setting the standard in a new and thriving industry.
Since April of 2016, the Company has shipped greater than 4,500,000 grams of oil and concentrates. It currently sells 200,000 grams of concentrates and oil a month. For the first half of 2019 Halo Labs had in excess of 18,000,000 dollars in Net Revenues (USD).
Halo Labs develops brands and provides white label manufacturing. Regarding areas of operation, the Company was founded in Oregon and is expanding to Nevada and California.
Halo Labs is developing brands for each segment of the market. This includes Ultra-Premium; Premium-Oregon; Edibles-Oregon; Mainstream-Oregon; Mainstream-Nevada;, and Everyday Value. In Oregon, Halo Labs has a +20 percent market share in wholesale concentrates. It has a 12,000 sq. ft. manufacturing facility in Medford, Oregon, and a 6 acres of outdoor canopy in Jackson County. For Hemp in Oregon, it has 7,500 sq. ft. purpose-built hemp manufacturing in Trent, Oregon.
In Nevada, Halo Labs has an 8,000 sq. ft. licensed processing facility by the Las Vegas Airport. The Company has 1,400 units per day estimated production capacity from its present 2,000 sq. ft. of operations.
In California, Halo Labs has 15,520 sq. ft. of licensed volatile & non-volatile processing facilities in Cathedral City. It has 5 contracts signed with Falcon International, Caliva, Nectar and Ikanik Farms. Halo has 12,000 grams per day estimated current production capacity from Facility 1. Furthermore, it has distribution partnerships with C4 Distro to deliver to 260 dispensaries in Southern California and Nabis who penetrates 99 percent of the California market.Peeks Social Ltd. (PKSLF
Halo Labs, Inc. (AGEEF), closed Tuesday's trading session at $0.3003, up 20.121%, on 469,771 volume with 243 trades. The average volume for the last 3 months is 366,699 and the stock's 52-week low/high is $0.153999999/$0.680000007.
Peeks Social Ltd. (PKSLF)
Stock Pulse, StockInvest.us, Stock Day Media, Cantech Letter, InvestorX, TeleTrader, OTC Markets, Market Screener, Mobile Marketer, Wallet Investor, TradingView, Seeking Alpha, TMXmoney, Nasdaq, Stockwatch, Stockhouse, GlobeNewswire, MarketWatch, InvestorsHub, Simply Wall St, Dividend.com, and GuruFocus reported earlier on Peeks Social Ltd. (PKSLF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Peeks Social Ltd. engages in the development and marketing of mobile video and livestreaming social media products. The Company does so under the Peeks Social brand for consumers and businesses in Canada. Peeks Social’s shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate office in Toronto, Ontario.
Peeks Social is a live streaming platform. A user can ‘go live’ and start broadcasting their stream from anywhere to anyone in the world. They can grow their followers overnight by getting featured in Peeks Social. In addition, they can explore by watching exclusive live streams and videos from around the world as well as receive special offers.
A user can become a broadcaster through downloading the Peeks Social App and start broadcasting. They can become a Peeks Social Influencer. One can join the Peeks Social Influencer program and increase their star power. In addition, they can get special deals and earn more coins.
Furthermore, one can earn money with Peeks Social through getting sponsored. A user can get automatically paired with an advertising partner based on the keywords in their stream title and earn money for each interaction.
At the end of October, Peeks Social announced that it filed its Unaudited Interim Consolidated Financial Statements for Q2 2020 and an Amended and Restated Q1 2020. Selected highlights for the three and six months ended August 31, 2019 (Q2 2020) include the Peeks Social platform producing Gross Revenue of $1.7 million during the six months period ended August 31, 2019. Gross Margin improved by 18 percent to 40 percent from 22 percent in the six months ended August 31, 2018.
Gross Revenues generated from the platform for the three months ended August 31, 2019 was $0.913 million with the same gross margin improvement of 17 percent to 42 percent from 25 percent in the same period of last year.
GAAP Net Loss decreased to $1.4 million in the six months ended August 31, 2019 from $2.3 million in the same period in 2018. For the three months ended August 31, 2019, GAAP Net Loss decreased to $0.75 million versus $1.6 million for the same period in 2018.
Peeks Social Ltd. (PKSLF), closed Tuesday's trading session at $0.0191, even for the day, on 363 volume. The average volume for the last 3 months is 3,627 and the stock's 52-week low/high is $0.0031/$0.086999997.
BlackStar Enterprise Group, Inc. (BEGI)
NetworkNewsWire, Stockflare, OTC Markets, TipRanks, Street Insider, Macroaxis, PitchBook, StockReads, OTC Dynamics, Last10k, GuruFocus, Morningstar, Simply Wall St, Market Screener, Wallet Investor, InvestorsHub, PR Newswire, Stockhouse, Nasdaq, and MarketWatch reported earlier on BlackStar Enterprise Group, Inc. (BEGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BlackStar Enterprise Group, Inc. is a specialized merchant banking firm listed on the OTC Markets Group’s OTCQB. The Company facilitates joint venture (JV) capital to early stage revenue companies. Its emphasis is on blockchain technology and it intends to gain exposure to the blockchain ecosystem via targeted JVs in the sector. The main concentration is on the distributed ledger security features and peer-to-peer (P2P) global equity trading arena.
Established in 2007, BlackStar Enterprise Group is headquartered in Boulder, Colorado. The Company previously went by the name BlackStar Energy Group, Inc. It changed its name to BlackStar Enterprise Group, Inc. in September of 2016.
The Company’s intention is to take advantage of its experience in the traditional world of public finance, including securities, options, registrations and SEC compliance, into working with select organizations supporting the development and implementation of new technologies in the crypto currency world. In addition, BlackStar is becoming an advocate and supporter of P2P equity trading on a distributed decentralized ledger that provides investment exposure to the fast growing blockchain ecosystems.
BlackStar Enterprise Group acts as a merchant bank providing access to capital for companies involved in crypto-equities with P2P trading. The Company will facilitate these companies, by way of majority controlled JVs with its subsidiary Crypto Equity Management Corp. This offers it shareholders entry into the ground-breaking crypto equity/cybersecurity space.
In November of 2018, BlackStar Enterprise Group announced the design and began the build of a digital equity trading platform on the Hyperledger-fabric blockchain. The platform will allow Peer-to-Peer trading of BlackStar Digital Shares of Common Stock. The design of the platform is to integrate into the existing Broker-Dealer Ecosystem. Regarding the BlackStar Digital Trading Platform (BDTP), the Company’s goal is to build BDTP from its existing design, a digital equity trading platform, to trade registered BlackStar securities only.
BlackStar Enterprise Group, Inc. (BEGI), closed Tuesday's trading session at $0.0469, up 91.4286%, on 8,725 volume with 5 trades. The average volume for the last 3 months is 87,673 and the stock's 52-week low/high is $0.021099999/$0.899999976.
Veritas Farms, Inc. (VFRM)
Alpha Stock News, Market Wire News, Teletrader, Biz Journals, Stock Target Advisor, OTC.Watch, Street Insider, Simply Wall St, Stockwatch, Investors Hangout, Trader Social Network, GuruFocus, Trading View, GlobeNewswire, Stockhouse, and MarketWatch reported earlier on Veritas Farms, Inc. (VFRM), and today we report on the Company, here at the QualityStocks Daily Newsletter.
A vertically-integrated agribusiness, Veritas Farms, Inc. concentrates on the production of full spectrum hemp extracts with naturally occurring cannabinoids. At present, it operates a 140-acre farm and production facilities in Pueblo, Colorado. The Company is registered with the Colorado Department of Agriculture to grow industrial hemp. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity. OTCQB-listed, Veritas Farms has its corporate headquarters in Fort Lauderdale, Florida.
Veritas Farms markets and sells products under its Veritas Farms™ brand. In addition, the Company manufactures private label products for several top distributors and retailers. Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in an array of size formats and flavors. Veritas produces the highest quality, full spectrum CBD (cannabidiol) products from its sustainable farm in Pueblo, Colorado.
The Company’s dedication is to sustainable farming methods. Additionally, Veritas has developed its own fertilizer, which helps balance out the local ecosystem. Veritas Farms employs drip irrigation. This ensures that every plant gets the proper hydration and that the Company conserves the Rocky Mountain water it uses. Veritas does not grow from seeds; it always cultivates from mother plants. Moreover, using clones allows Veritas to maintain genetic stability.
Recently, Veritas Farms announced that Fruth Pharmacy will start selling Veritas Farms™ brand hemp oil products at 15 store locations in West Virginia. Veritas Farms™ brand hemp oil products available at Fruth Pharmacy will include full spectrum tinctures, moisturizing lotions, salves, and lip balms, and popular gummies.
Veritas Farms also recently announced that its topical products will be featured nationwide in 945 Kroger Family of Stores. This includes banners Kroger, Dillons, Fry’s, Fred Meyer, King Soopers, Mariano’s, Pick ‘n Save, QFC and Smith’s, across 17 states (Arizona, Arkansas, Colorado, Illinois, Indiana, Kansas, Kentucky, Michigan, Missouri, Nevada, Oregon, South Carolina, Tennessee, West Virginia, Washington, Wisconsin, and Wyoming).
Veritas Farms, Inc. (VFRM), closed Tuesday's trading session at $1.74, up 45.00%, on 119,461 volume with 174 trades. The average volume for the last 3 months is 33,106 and the stock's 52-week low/high is $1.00/$9.15999984.
Integrity Applications, Inc. (IGAP)
Stockflare, Wallet Investor, MarketWatch, Simply Wall St, Stockopedia, PR Newswire, SmallCapVoice, Morningstar, Market Exclusive, Wallmine, Market Screener, OTC Markets Group, GuruFocus, Capital Cube, and YCharts reported previously on Integrity Applications, Inc. (IGAP), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Integrity Applications, Inc. is the maker of GlucoTrack® - a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes. GlucoTrack® is a monitoring device that quickly measures and displays an individual's glucose level in about a minute without finger pricking or any pain. OTCQB-listed, Integrity Applications is headquartered in Wilmington, Delaware. The Company has a research and development (R&D) site in Ashdod, Israel.
Integrity Applications is focusing on three important initiatives - GlucoTrack Commercialization in Europe; GlucoTrack U.S. FDA (Food and Drug Administration) Approval; and a Product Roadmap. The Company’s initial principal emphasis is on the commercialization of GlucoTrack in Europe. GlucoTrack® has received CE Mark and KFDA approvals for type 2 diabetes and pre-diabetes. It is now in the early stages of commercialization in Europe, South Korea, as well as other geographies.
GlucoTrack® features a small sensor. This sensor clips to the earlobe and measures the user's glucose level using inventive and patented sensor technology. The measured signals undergo analysis using a proprietary algorithm and subsequently a calculated glucose level is displayed on a small handheld device the size of a small mobile phone.
The glucose results are stored in the device and used to project an estimated HbA1c level using a proprietary algorithm. The device can also display glucose values graphically. This allows the user to monitor glucose levels over time. GlucoTrack® is presently experimental in the United States. It is limited to investigational use only.
In December of 2018, Integrity Applications announced that it launched a Customer Experience Program in the Netherlands with its exclusive distributor MediReva and renowned clinical thought leaders in the field of diabetes care. The chief purpose of this program is to demonstrate real-world patient and health care professional experience with GlucoTrack® as a solution for daily glucose monitoring, and to further hasten commercialization and the reimbursement process in the Netherlands.
Integrity Applications, Inc. (IGAP), closed Tuesday's trading session at $0.75, up 37.1115%, on 526 volume with 5 trades. The average volume for the last 3 months is 1,883 and the stock's 52-week low/high is $0.100000001/$0.75999999.
Alpine 4 Technologies Ltd. (ALPP)
Stockhouse, MarketWatch, Proactive Investors, Investors Hangout, Uptick Newswire, Wallet Investor, GuruFocus, TradingView, InvestorsHub, OTC Markets, Barchart, Market Screener, Financial Content, Investor Place, and Capital Cube reported earlier on Alpine 4 Technologies Ltd. (ALPP), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Alpine 4 Technologies Ltd. is a technology and manufacturing holding company. It has business-related endeavors in Automotive Technologies, Electronics Manufacturing, Software and Data Technologies. Established in 2014, Alpine 4 Technologies has its corporate headquarters in Phoenix, Arizona. The Company lists on the OTC Markets’ OTCQB.
Alpine 4’s’s subsidiaries and product groups include ALTIA; Quality Circuit Assembly (QCA); and Venture West Energy Services. ALTIA is an automotive products company. The Quality Circuit Assembly (QCA) subsidiary provides electronic contract manufacturing solutions delivered to its customers through strategic business partnerships. Venture West Energy Services centers on supporting the oil and gas industry in Texas, Oklahoma, and Arkansas.
The Company’s focus is on how the adaptation of new technologies, even in brick and mortar businesses, can increase innovation. The core of its acquisition strategy is its emphasis on existing smaller middle market operating companies with Revenues of $5 to $50 million.
The design of Alpine 4 Technologies is to allow its subsidiaries room to develop their own identities and synergistically prosper from inter-company resources and collaboration. Alpine 4 will own controlling interest in every subsidiary. Moreover, it will also have direct control over planning and management.
Alpine 4 Technologies completed its acquisition of American Precision Fabricators, Inc. (APF) in 2018. The acquisition adds to Alpine 4’s technology manufacturing sector play, which started in 2016 with its purchase of Quality Circuit Assembly (QCA). This is the fourth acquisition that Alpine 4 Technologies has made in two years.
Recently, Alpine 4 Technologies announced that it concluded its beta pilots of SPECTRUMebos. This is a blockchain Enterprise Business Operating System that it started developing in 2017. The Company anticipates moving those pilot sessions to full production in Q1 2019 with its subsidiaries: Quality Circuit Assembly and American Precision Fabricators.
SPECTRUMebos is an Enterprise Business Operating System (EBOS) developed by Alpine 4 Technologies. It combines the key technology software components of Accounting and Financial Reporting with that of an Enterprise Resource Planning System (ERP), a Document Management System (DMS), a Business Intelligence (BI) platform and a Customer Resource Management (CRM) hub that are all tied to a management reporting and collaboration toolset.
Alpine 4 Technologies continued with its DSF acquisition strategy last week with the announcement that it completed the acquisition of Morris Sheet Metal, Corp. and JT Spiral (MSM). Alpine 4 took effective control of the companies on January 1, 2019. The acquisitions are the first for Alpine 4's construction services holdings portfolio.
Morris Sheet Metal and JT Spiral were formed in 1992. They primarily service large industrial clients in the food manufacturing industry. Their services include design, fabrication and installation of dust collectors, commercial ductwork, kitchen hoods, industrial ventilation systems, machine guards, architectural work, water furnaces and much more.
Alpine 4 Technologies Ltd. (ALPP), closed Tuesday's trading session at $0.166, up 48.2143%, on 12,993,310 volume with 1,596 trades. The average volume for the last 3 months is 3,491,575 and the stock's 52-week low/high is $0.005599999/$0.439999997.
Bravada Gold Corp. (BGAVF)
Gold Investment Letter, Penny Stock Hub, 4-Traders, NorthernVertex, Stockhouse, Morningstar, Cambridge House International, The Street, Dividend Investor, The Prospector News, and Real Pennies reported on Bravada Gold Corp. (BGAVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Bravada Gold Corp. is a Nevada-focused exploration and development company. It has a large portfolio of high-quality properties. These properties include a range of development stages. This is from early-stage exploration to advanced-stage exploration and pre-development. Bravada Gold is based in Vancouver, British Columbia and the Company lists on the OTC Markets Group’s OTCQB.
Bravada Gold retains residual working or royalty interests. The Company explores for precious metals in well-established gold trends in one of the world’s best gold jurisdictions.
At present, five of Bravada’s Nevada properties are being backed by partners. In total this includes earn-in work expenditures of up to $6.5 million and payments to Bravada Gold of up to +$3.0 million in cash and shares. Bravada holds a royalty on eventual barite production on its Shoshone Pediment Project.
Regarding its Wind Mountain project, the Company’s plan is to drill-test for high-grade “Hishikari-type” gold/silver vein mineralization under the existing disseminated resource at Wind Mountain. Pertaining to the SF property, Bravada Gold plans to drill-test for high-grade “Carlin-type” gold mineralization at the property.
Concerning the North Lone Mountain and South Lone Mountain projects, plans have not been finalized for Bravada Gold’s two claim groups. However, Nevada Zinc continues to expand the footprint of zinc mineralization on its claims towards Bravada Gold’s South Lone Mountain claims. Should Nevada Zinc complete the purchase of these claims, Bravada will retain a royalty on base and precious metals.
Bravada Gold received earlier this year, subject to posting a reclamation bond, approval of its drilling permit from the U.S. Forest Service for its Quito Gold property. The permit allows four sites to be drilled at the Quito Extension target in 2018. Numerous holes can be drilled from these sites. The Quito Property is situated along the Austin Gold trend in central Nevada.
Bravada Gold, by way of its wholly-owned U.S. subsidiary Bravo Alaska, Inc., and Yamana Gold, Inc., through its wholly-owned U.S. subsidiary Meridian Minerals Corp. (collectively Yamana), have agreed to amend the earn-in agreement for the Quito Property.
This amendment will remove a "Claw-back" provision, which allowed Yamana Gold to re-acquire a 51 percent ownership in Quito after earn-in by Bravada Gold of a 70 percent working interest (WI) in the property with all other terms remaining constant. As consideration for the amendment, Yamana Gold receives 1,000,000 common shares in Bravada Gold and warrants to buy 1,000,000 common shares at CDN$0.15 for a period of three years.
Recently, Bravada Gold announced that the earlier announced $480,000 non-brokered private placement has been oversubscribed. The Company will now issue 6,584,000 units in a non-brokered private placement at a price of $0.08 per Unit for gross proceeds of $526,720. Net proceeds from the private placement will be used for property maintenance fees, permitting fees and associated ancillary costs, and accounts payable and for working capital.
Bravada Gold Corp. (BGAVF), closed Tuesday's trading session at $0.055, up 36.1386%, on 22,000 volume with 8 trades. The average volume for the last 3 months is 61,359 and the stock's 52-week low/high is $0.037939999/$0.154200002.
Guided Therapeutics, Inc. (GTHP)
NYC Marketing Inc., DSR News, PHUB News, TheNextBigTrade, PennyStocks24, TopPennyStockMovers, SmallCapVoice, PennyTrader Publisher, Pennystocktweeters.com, Stock Beast, OTCStars.com, BestDamnPennyStocks, PennyStockLocks.com, ResearchOTC, Stock Commander, StockRockandRoll, AllPennyStocks, and Momentum Trades reported on Guided Therapeutics, Inc. (GTHP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Guided Therapeutics, Inc. is the creator of a fast and painless testing platform. This platform is for the early detection of disease founded on the Company's patented biophotonic technology that uses light to detect disease at the cellular level. The Company’s initial product is the LuViva® Advanced Cervical Scan. This is a non-invasive device used to detect cervical disease rapidly and at the point of care. Guided Therapeutics has its corporate office in Norcross, Georgia.
The LuViva® Advanced Cervical Scan is an investigational device. It is limited by federal law to investigational use in the United States. The design of LuViva® is as a fast, painless test that, unlike Pap smears and HPV testing, does not necessitate a tissue sample or the delay of laboratory analysis.
LuViva® scans the cervix with light. It utilizes spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of pre-cancer, which may be below the surface of the cervix or misdiagnosed as benign.
This technique is called biophotonics. Biophotonics is the science of generating and harnessing light to image, detect, as well as manipulate biological materials.
The LuViva® Advanced Cervical Scan technology (in a multi-center clinical trial, with women at risk for cervical disease) was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. The device is used in combination with the LuViva® Cervical Guide single-use patient interface and calibration disposable.
The LuViva® Advanced Cervical Scan is under U.S. Food and Drug Administration (FDA) Premarket review. Guided Therapeutics is also developing a non-invasive test for the early detection of esophageal cancer utilizing this technology platform.
Recently, Guided Therapeutics reported record sales for a quarter in Indonesia; eight LuViva® Advanced Cervical Scans were shipped in Q4 of last year. Furthermore, Indonesia ordered 4,500 single-use Cervical Guides that were shipped along with the LuViva devices.
This increase in orders of high-margin Cervical Guides indicates that installed LuViva units are starting to see more usage in hospitals and clinics. Founded on prior studies and evaluations of LuViva, medical researchers in Indonesia are recommending the LuViva test as an alternative to the Pap test for cervical cancer screening.
In addition, Guided Therapeutics recetnyl reported that it received Regulatory Approval from the Indian Ministry of Health & Family Welfare to permit commercialization of the LuViva device and disposables. The Ministry concluded that the LuViva device is “Non Invasive” and therefore is “not regulated under the Drugs and Cosmetics Act 1940 and Medical Device Rules 2017 thereunder.” Consequently, LuViva can now be commercialized in India.
Guided Therapeutics, Inc. (GTHP), closed Tuesday's trading session at $0.19975, up 30.9836%, on 1,780 volume with 5 trades. The average volume for the last 3 months is 4,976 and the stock's 52-week low/high is $0.0206/$1.45000004.
HD View 360, Inc. (HDVW)
OTC Markets, MarketWatch, TradingView, and MarketNewsUpdates reported on HD View 360, Inc. (HDVW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A full-service Information Technology (IT) company, HD View 360, Inc. and its subsidiary companies are a complete Business-to-Business (B2B) Information Technology solution. The Company provides hardware installation, security monitoring systems, telephone services, merchant processing, Point-of-Sale (POS) software, and continuing IT support to small and medium-sized businesses (SMBs). HD View 360 is headquartered in Miami, Florida.
The Company has practical experience in almost every aspect of retail operations. One of HD View 360’s wholly-owned subsidiaries is SimpleFone. This subsidiary is an innovative Voice over Internet Protocol (VoIP) provider. At present, SimpleFone is selling its telephone services to numerous nationally-recognized franchise brands. HD View 360 is positioning SimpleFone to become a foremost VoIP carrier.
SimpleFone has secured a data housing center close to its headquarters in Miami, with a redundancy center in Phoenix, Arizona. It also purchased a new VoIP phone switch that can service up to 100,000 phone lines at the same time.
Recently, SimpleFone has been overhauling its infrastructure to prepare for an influx in growth by launching a more consumer-driven website, introducing its Simple Affiliate Partner sales program, implementing new software and POS/CRM integration functionality, and creating a much safer and secure SRTP/TLS compliant encryption platform. By way of these upgrades, and more, SimpleFone’s plan is to further support its increasing list of consumer and investor needs.
HD View 360 and Voice Solutions, Inc. announced last month a new strategic partnership. This partnership will take advantage of access to enterprise-level customers and create mutual avenues of recurring revenue streams for both businesses.
Voice Solutions is one of the top providers of in-store music, on-hold message services, digital signage, sound masking, and other impactful sensory marketing services. Voice Solutions is the first member of HD View 360’s Simple Affiliate Partner Program.
HD View 360 recently announced the launched of development of its proprietary POS Software via its wholly-owned subsidiary, HD View Technologies. The specific design of this POS solution is with the franchise and multi-location retail segment in mind.
The Company’s POS solution will seamlessly integrate its client's businesses, products, customers, and payment systems into one user-friendly platform. The next generation POS software will take advantage of HD View 360's merchant processing service and its years of experience working with franchise brands to provide clients with a complete and specialized retail solution.
Recently, HD View 360 announced that subsidiary HD View Technologies signed its first Letter of Intent (LOI) with Pizzafire. This is to supply its POS technology to all locales across the country. The next generation POS will enable the growing restaurant chain to more efficiently staff, save time on menu updates, as well as keep closer tabs on new locations.
Of note is that 19 Pizzafires are open, 15 more are planned by the end of 2017, and there are numerous POS systems per location. HD View 360’s anticipation is that this contract will be a considerable revenue generator in the months ahead.
HD View 360, Inc. (HDVW), closed Tuesday's trading session at $0.001, up 900.00%, on 1,000 volume with 1 trade. The stock's 52-week low/high is $0.000009999/$0.0005.
The QualityStocks Company Corner
- No Borders Inc. (OTC: NBDR)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Sigma Labs Inc. (NASDAQ: SGLB)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Marijuana Company of America (OTCQB: MCOA)
- SRAX Inc. (NASDAQ: SRAX)
- Predictive Oncology (NASDAQ: POAI)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- HTC Extraction Systems (TSX.V: HTC)
- Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
- Quest Patent Research Corp. (OTCQB: QPRC)
- SinglePoint, Inc. (SING)
- LiveWire Ergogenics Inc. (OTC: LVVV)
No Borders Inc. (OTC: NBDR)
No Borders Inc. (OTC: NBDR), a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies designed to reduce costs and increase shareholder value, today announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW"). Also today, InvestorBrandNetwork released a detailed report on the company detailing how No Borders Inc. (NBDR) is “One to Watch.”
No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.
Different by Design
Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.
The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.
With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.
- No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
- No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
- No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
- No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
- No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.
No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.
COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.
CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.
Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.
No Borders Inc. (NBDR), closed Tuesday's trading session at $0.016, up 6.6667%, on 40,807 volume with 3 trades. The average volume for the last 3 months is 77,461 and the stock's 52-week low/high is $0.007699999/$0.048799999.
- Coverage Initiated for No Borders Inc. via NetworkNewsWire
- No Borders Inc. (NBDR) is “One to Watch”
- No Borders Inc. (NBDR) Files Q3 Financials Early, Reports Another Record Quarter of Growth
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today in a publication from Financialnewsmedia.com, examining how international support for CBD has been explosive. At the moment, one in seven Americans say they personally use cannabidiol-based products, says a recent Gallup poll, which has only proliferated since the passage of the U.S. Farm Bill. However, those numbers are likely to increase as more CBD makes its way on to shelves. In fact, the Brightfield Group estimates the U.S. CBD product market alone to be worth over $23.7 billion by 2023, as CBD finds its way into a variety of consumer product categories including food and beverage, pharmaceuticals, cosmetics, and health and wellness. Also today, the company was highlighted in a publication from Motley Fool, examining how marijuana stocks in general received a boost after the U.S. House of Representatives Judiciary Committee announced on Monday that it plans to vote this week on proposed legislation to legalize marijuana in the U.S. As one of the financially stronger Canadian cannabis producers, OrganiGram enjoyed a bigger gain than most of its peers.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Tuesday's trading session at $2.32, up 12.6214%, on 3,631,203 volume with 10,640 trades. The average volume for the last 3 months is 1,770,304 and the stock's 52-week low/high is $2.00/$8.43999958.
- This is Why CBD Will Remain One of the Hottest Investment Stories
- Why OrganiGram Holdings Shares Jumped Today
- Cross-Pollination Triggers Disputes Between Hemp and Marijuana Farmers
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Focusing on offering a consistent cannabis experience, Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF)produces edibles using extracts to ensure compliant, dosable and flavorful products supporting a healthy and active lifestyle. Headquartered in San Mateo, California, the company is fundamentally a branded, cannabis-infused products manufacturer, offering the #1 best-selling Cannabis products in California according to BDS Analytics. The company’s product team consists of chefs, chemists, food-manufacturing experts.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Tuesday's trading session at $1.4048, up 17.9909%, on 49,133 volume with 84 trades. The average volume for the last 3 months is 39,536 and the stock's 52-week low/high is $1.08749997/$6.00810003.
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Focused on Owning Branded-CBD Space
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Appoints First-Ever Chief Scientific Officer
- Why Full Spectrum CBD Products Are Superior to Those Having Isolates
Sigma Labs Inc. (NASDAQ: SGLB)
Sigma Labs Inc. (NASDAQ: SGLB) (SGLB Profile) is on the verge of unleashing the dynamic forces of additive metal manufacturing that have been restrained. Long heralded as the fourth industrial revolution, 3D metal printing and its full potential have been stalled due to the high cost and complexities of end-product inspection and quality control. Sigma Labs’ PrintRite3D(R) software represents a seismic shift in the quality-assurance process in the manufacture of 3D-printed metal components, and the entire sector is poised for extraordinary growth.
Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.
For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.
Revolutionizing Additive Manufacturing
Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.
Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.
Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.
Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.
Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.
Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.
Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.
Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.
Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.
John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.
Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.
CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.
Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.
Sigma Labs Inc. (SGLB), closed Tuesday's trading session at $0.90, up 1.1236%, on 379,664 volume with 693 trades. The average volume for the last 3 months is 161,426 and the stock's 52-week low/high is $0.451099991/$2.46000003.
- Profiting from the Fourth Industrial Revolution
- Sigma Labs Inc. (NASDAQ: SGLB) Transforming the Creation of Critical 3D Metal Printing Components
- Sigma Labs, Inc. (NASDAQ: SGLB) Posts Q3 2019 Financial Results
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced its receipt of orders from Alberta, Manitoba and Nova Scotia to be shipped this month, significantly expanding its Canadian distribution footprint. To view the full press release, visit http://cnw.fm/vT9Wp. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. On Thursday, Pew Research Center released the 2019 polling results on support for marijuana legalization which showed an increase with more than two-thirds of Americans backing the policy.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Tuesday's trading session at $0.5485, up 10.8081%, on 1,922,633 volume with 1,010 trades. The average volume for the last 3 months is 1,118,775 and the stock's 52-week low/high is $0.469300001/$4.38000011.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Significantly Expands Canadian Distribution Footprint
- 420 with CNW – Pew Poll Finds Increased Support for Marijuana Legalization
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q3 2019 Results
Marijuana Company of America Inc. (MCOA)
Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA)today announced that its hempSMART(TM) brand products have been nominated by the Los Angeles Business Journal for its 2019 Fashion & Beauty Awards. To view the full press release, visit http://cnw.fm/kOHo7
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Tuesday's trading session at $0.151, up 9.8182%, on 249,933 volume with 133 trades. The average volume for the last 3 months is 309,427 and the stock's 52-week low/high is $0.023/$2.10599994.
- Marijuana Company of America Inc. (MCOA) hempSMART(TM) Brand Receives Los Angeles Business Journal 2019 Fashion and Beauty Awards Nomination
- Cross-Pollination Triggers Disputes Between Hemp and Marijuana Farmers
- 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
SRAX Inc. (NASDAQ: SRAX)
Digital-marketing and consumer-data-management technology platform company SRAX (NASDAQ: SRAX) has developed a consumer-managed data marketplace via its BIGtoken platform that enables people to own and earn from their data. To view the full article, visit http://nnw.fm/gmZZ9.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $1.55, even for the day, on 36,160 volume with 177 trades. The average volume for the last 3 months is 93,847 and the stock's 52-week low/high is $1.40999996/$5.8499999.
- SRAX Inc.’s (NASDAQ: SRAX) BIGtoken App Makes Owning, Monetizing Personal Data Possible
- SRAX Reports Q3 2019 Vertical Sales Increase 17% Year-over-Year and Net Income of $1.4 Million
- SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Numbers 16 Million-Plus as Consumers Respond to Opt-In Data Management
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology (NASDAQ: POAI), an artificial intelligence (“AI”) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through innovative data-driven products and services, this morning announced the broadcast of a NetworkNewsAudio (“NNA”) interview with Stuart Smith of NetworkNewsWire (“NNW”). To view the full press release, visit http://nnw.fm/jFY68. Also today, InvestorBrandNetwork released a report on the company detailing how, as the precision-medicine industry continues to integrate technology to improve the efficiency and efficacy of its strategies, clinicians are realizing the need for actual patient samples to determine the best methods to defeat cancer. Researchers are now turning to patient-derived tumors (PDx) to better understand the complexities and vagaries of the disease which has become the new focus in cancer research.
Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.
Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:
- A database of clinically validated historical and outcome data from patient tumors
- An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
- A “smart” patient-derived tumor profiling platform
- An in-house bioinformatics artificial intelligence (AI) platform
- A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
- An FDA-approved fluid collection and disposal system
Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.
Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.
Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.
Predictive Oncology (POAI), closed Tuesday's trading session at $3.70, off by 5.1282%, on 29,502 volume with 189 trades. The average volume for the last 3 months is 16,347 and the stock's 52-week low/high is $3.31999993/$8.50.
- Predictive Oncology Inc. (NASDAQ: POAI) CEO Discusses Corporate, Scientific Milestones in NetworkNewsAudio Interview
- Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Technology May Prove Critical in New Cancer Drug Development
- Predictive Oncology Inc. (NASDAQ: POAI) Reports Q3 Results, 58% Revenue Increase
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was highlighted today in a publication from Investing News Network, examining how, in December 2019, just over a year after the legalization of adult-use cannabis, Canada will undergo a second wave of cannabis legalization.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.4527, off by 5.6875%, on 54,906 volume with 44 trades. The average volume for the last 3 months is 91,476 and the stock's 52-week low/high is $0.399800002/$1.6875.
- Marijuana Stocks Targeting the Cannabis Beverages Market
- 420 with CNW – Lottery Held to Award Recreational Weed Locations to Chicago Applicants
- Hemp Researcher Files Billion Dollar Claim Against County in California
HTC Extraction Systems (TSX.V: HTC)
HTC Extraction Systems (TSX.V: HTC) was featured today in a publication from CBDWire, examining how the hemp industry has been through a rollercoaster of legislation over the past few years. First, the 2018 Farm Bill made the cultivation of industrial hemp legal, and by extension, making the marketing and sale of hemp-derived CBD legal. This was followed by the USDA’s interim rule on hemp in October 2019 which provided a regulatory framework for the rapidly growing sector.
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Tuesday's trading session at $0.255, off by 7.2727%, on 55,500 volume with 13 trades. The average volume for the last 3 months is 120,620 and the stock's 52-week low/high is $0.079999998/$1.24.
- New Jersey Senate Passes Bill Urging Feds to Enact CBD Dosage Guidelines
- 420 with CNW – Georgia’s Medical Marijuana Program Kicks into High Gear
- HTC Extraction Systems (TSX.V: HTC) Positioned to Capitalize on Market Forecasted to Reach $22 Billion by 2022
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF), a producer of high-quality feature films and episodic television with international appeal, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), a NetworkNewsWire (“NNW”) solution. In the interview, Wonderfilm Media CEO Kirk Shaw joins NNW’s Stuart Smith to discuss the company’s business model in producing quality theatrical releases and entertainment content for an expanding array of streaming services. To view the full press release, visit http://nnw.fm/zq5Gi.
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.
Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.
Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.
The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.
Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.
Management Team with Proven Track Records
Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.
Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.
Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.
Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.
Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.
17-Title Movie Slate — Greenlit
Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.
Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.
The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.
Potential for Breakout Success
Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.
Note: Potential breakout films are not factored into company’s revenue projections.
Base Hits and Home Runs
In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.
Recent Industry Breakout Films Include:
- SAW – $1.2 million budget = $103.9 million in sales
- Pulp Fiction – $8 million budget = $212 million in sales
- My Big Fat Greek Wedding – $5 million budget = $250 million in sales
- Lost in Translation – $4 million budget = $120 million in sales
- Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)
Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.
Recent Wonderfilm Releases
- Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
- Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
- Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
- Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.
Wonderfilm Global Distribution
At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.
Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.
The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.
A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.
Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.
Wonderfilm Business Model
Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.
Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.
Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.
Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.
Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.
Sales overages once contracted presale threshold is surpassed.
The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.
Note: The nature of the film business is that box office revenue lags production up to a couple of years.
$50 Million Wonderfilm Production Fund (WPF):
Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.
The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.
For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.
All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.
Wonderfilm Media Corporation (OTC: WDRFF), closed Tuesday's trading session at $0.12, off by 15.0142%, on 90,000 volume with 14 trades. The average volume for the last 3 months is 42,779 and the stock's 52-week low/high is $0.075099997/$0.504400014.
- Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) CEO Discusses Production, Talent and Expansion in Exclusive Audio Interview
- Wonderfilm Media Corporation’s (TSX.V: WNDR) (OTCQB: WDRFF) Production Star Rising with Low-Risk Budget Model, Boom in Streaming Services
- Wonderfilm Media Corp.’s (TSX.V: WNDR) (OTCQB: WDRFF) Latest Theatrical Premiere Features Steven Seagal, DMX and Johnny Messner in “BEYOND THE LAW”
Quest Patent Research Corp. (OTCQB: QPRC)
The Anchor Structure Portfolio, acquired by company Quest Patent Research Corp. (OTCQB: QPRC)from Intellectual Ventures in October 2015 and transferred to wholly owned subsidiary, Mariner IC Inc., consists of two United States patents which relate to technology for incorporating metal structures in the corners and edges of semiconductor dies to prevent cracking from stresses.
Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.
Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.
Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:
- IP Valuation
- Structured Licensing Programs
- Patent Prosecution
- Partial or Full Liquidity
- Portfolio Evaluation
- Portfolio Maintenance
- Legal Advisory
- Attorney/Investor Referral
- Patent Acquisition/Liquidation
At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.
Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.
Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.
Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.
Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.
Quest Patent Research Corp. (OTCQB: QPRC), closed Tuesday's trading session at $0.0116, off by 4.1322%, on 394,819 volume with 22 trades. The average volume for the last 3 months is 276,946 and the stock's 52-week low/high is $0.004499999/$0.039999999.
- Quest Patent Research Corp. (QPRC) Completes Another Successful Licensing Campaign
- Quest Patent Research Corp. (QPRC) Maintains Robust Portfolio of Diverse IP Assets
- Quest Patent Research Corp. (QPRC) Creates Shareholder Value Through a Broad Portfolio of Protected IP Assets
SinglePoint, Inc. (SING)
Direct Solar a subsidiary of SinglePoint Inc. (OTCQB:SING), a leading residential and commercial solar brokerage, continues to exceed revenue growth targets and has been pivotal to improving the Company’s financials. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. On Thursday, Pew Research Center released the 2019 polling results on support for marijuana legalization which showed an increase with more than two-thirds of Americans backing the policy.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.01064, off by 1.0233%, on 3,076,085 volume with 118 trades. The average volume for the last 3 months is 2,689,259 and the stock's 52-week low/high is $0.009999999/$0.028799999.
- Solar Stock News: SinglePoint Subsidiary Direct Solar Making Major Headway as Expansion Continues
- 420 with CNW – Pew Poll Finds Increased Support for Marijuana Legalization
- SinglePoint Inc. (SING) Surging in $52.5 Billion Global Solar Market, Sees Solar Division Hitting $5 Million in Contracts by End of 2019
LiveWire Ergogenics Inc. (OTC: LVVV)
LiveWire Ergogenics Inc. (OTC: LVVV) was featured today in a publication from CBDWire, examining how the hemp industry has been through a rollercoaster of legislation over the past few years. First, the 2018 Farm Bill made the cultivation of industrial hemp legal, and by extension, making the marketing and sale of hemp-derived CBD legal. This was followed by the USDA’s interim rule on hemp in October 2019 which provided a regulatory framework for the rapidly growing sector.
LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.
During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:
PODs and Distribution in Coachella, California
For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.
Estrella Ranch in Paso Robles, California
Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.
The Paso Robles Nursery
LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.
LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.
GHC Ventures Subsidiary
GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.
GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.
LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.
LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.
7X Pure™ Dosing and Verification System
LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.
The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.
The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.
Acquisitions & Operations
To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.
Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.
The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.
LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.
LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.
Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.
As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.
Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.
Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.
Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.
Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.
Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.
LiveWire Ergogenics Inc. (OTC: LVVV), closed Tuesday's trading session at $0.0039, off by 13.3333%, on 497,575 volume with 12 trades. The average volume for the last 3 months is 1,198,842 and the stock's 52-week low/high is $0.0038/$0.037399999.
- New Jersey Senate Passes Bill Urging Feds to Enact CBD Dosage Guidelines
- LiveWire Ergogenics Inc. (LVVV) Announces Financial Report for Q3 2019
- LiveWire Ergogenics Inc. (LVVV) Transforming Historic Paso Robles Ranch Property Into High-End Cannabis Facility and Wellness Retreat
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Entry into Second Phase Development of Immersive Educational Materials
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Comments on Recent Unauthorized Promotional Activity in Response to OTC Markets Request
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Reports Q2 Fiscal Year 2020 Financial Results, Provides Corporate Update
- ChineseInvestors.com (CIIX) CEO Featured in RedChip Money Report Interview, Describes Tremendous Opportunity in China’s CBD Cosmetics Market
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Puts Cultivation on Hold to Focus on Extraction, Edibles and Distribution
- CloudCommerce (OTCQB: CLWD) Benefiting from Dramatic Transition to Digital Advertising
- Dama Financial - Enters Strategic Partnership with PayWana
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse(R) Reduces Opioid Prescriptions at New Hanover Regional Medical Center
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Third Quarter 2019 Financial Results
- Genprex, Inc. (NASDAQ: GNPX) Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month
- GP Solutions (GWPD) Announces Launch of “Prolific Soilless Growth Medium” and “Prolific Hydro” on Amazon
- Grapefruit Boulevard Investments Inc. (IGNG) Can CBD Help Cure Hangovers?
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Survey Shows Americans Think the FDA Regulates the CBD Industry
- Green Hygienics Holdings Inc. (OTC: GRYN) 420 with CNW – What You Need to Know to Grow Marijuana in a Greenhouse
- Hemptown USA - Premier CBG Grower Worldwide, Expects Significant Revenue Boost in 2020
- HTC Extraction Systems (TSX.V: HTC) 420 with CNW – Georgia’s Medical Marijuana Program Kicks into High Gear
- InsuraGuest Inc. - Provides First Line of Defense for Vacation Rental Industry and Guests
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Cannabidiol Can Help to Manage Endometriosis Pain, New Study
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Cannabidiol Can Help to Manage Endometriosis Pain, New Study
- LiveWire Ergogenics Inc. (OTC: LVVV) Announces Financial Report for Q3 2019
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
- MCTC Holdings Inc. (MCTC) USDA Hemp Testing Rules Invalidate Washington’s Preferred Protocol
- MustGrow Biologics Corp (CSE: MGRO) Intends to Tackle New Fusarium Pathogen Threatening Worldwide Banana Supply
- Neutra Corp. (OTCQB: NTRR) How the National Hemp Rules Could Affect Idaho
- Nightfood, Inc. (OTCQB: NGTF) Presenting at Today’s “Next Super Stock Live!” Online Investor Conference Hosted by Wall Street Reporter
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Cannabis Weekly Round-Up: Quarterly Updates Rock Market
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- OriginClear (OCLND) Sees Major Opportunity as the Permian Basin Experiences Water Shortage
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Successful Completion of Phase 1 Nickel/Cobalt Process Recovery Program
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Anticipated Automation Completion Date
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Appoints First-Ever Chief Scientific Officer
- Predictive Oncology Inc. (NASDAQ: POAI) Reports Q3 Results, 58% Revenue Increase
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
- Quest Patent Research Corp. (QPRC) Maintains Robust Portfolio of Diverse IP Assets
- Sharing Services Global Corporation (SHRG) Leading the Way Forward in World of Changing Needs for Consumers, Workers
- Sigma Labs, Inc. (NASDAQ: SGLB) Transforming the Creation of Critical 3D Metal Printing Components
- SinglePoint, Inc. (SING) Surging in $52.5 Billion Global Solar Market, Sees Solar Division Hitting $5 Million in Contracts by End of 2019
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $950K Purchase Order from Top US Distributor
- Spectrum Global Solutions, Inc. (SGSI) Announces Closing of WaveTech GmbH Acquisition
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
- SRAX Inc. (NASDAQ: SRAX) Reports Q3 2019 Vertical Sales Increase 17% Year-over-Year and Net Income of $1.4 Million
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate in Two Upcoming Industry Conferences
- Sugarmade, Inc. (SGMD) Announces Ambitious Strategy as it Advances Plans to Uplist to Major US Exchange
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Blissco Launches New, Full-Spectrum CBD Oil, Pur Dew
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) USDA Hemp Testing Rules Invalidate Washington’s Preferred Protocol
- Trxade Group Inc. (TRXD) Bonum Health Unveils Next-Gen Healthcare Solution Coming Soon to Independent Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – What Women Should Know About Marijuana and Breast Cancer
- VPR Brands, LP (VPRB) How the National Hemp Rules Could Affect Idaho
- Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Production Star Rising with Low-Risk Budget Model, Boom in Streaming Services
- Xalles Holdings Inc. (XALL) Offering Solutions in E-Commerce, Payments, Financial Reconciliation Sectors
- Youngevity International, Inc. (NASDAQ: YGYI) to Host November 18th Conference Call to Review Financial Statements, Provide Corporate Update
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.